Researchers have discovered that a mutation of the MDGA1 gene, a key factor modulating the connections and characteristics between nerve cells, serves as a new cause of autism spectrum disorder (ASD), and suggested the possibility […]
The cells that line the blood vessels in our brains are highly selective. By deciding which molecules are allowed in and out of our most important organ, the barrier these cells form is critical for […]
A new analysis from UC San Francisco argues that diagnostics—medical tests that match patients to the appropriate treatment—are being overlooked both in the United States and around the world. This is slowing progress against major […]
A new flu treatment could drastically reduce one of flu’s deadliest complications—bacterial pneumonia—by helping the lungs defend themselves, rather than targeting the virus directly. Influenza specialist Associate Professor Michelle Tate’s latest research has shown that […]
Amid a renaissance in the science of psychedelics, public interest in psilocybin—or magic mushrooms, as they’ve long been known—is surging.This article was originally published on MedicalXpress.com
Amlitelimab, a fully human non-T cell depleting monoclonal antibody that selectively targets OX40-ligand (OX40L), is safe and effective, with potentially progressive efficacy over time, for patients with moderate-to-severe atopic dermatitis (AD), according to the results […]
Antibody therapeutics are laboratory-made proteins designed to work like the body’s natural antibodies. They are widely used to treat diseases such as cancer by binding to specific targets, including cancer cells or inflammatory molecules. However, […]
Levodopa—the gold-standard treatment for Parkinson’s disease—increases dopamine in the brain. But as the disease progresses in severity, patients often need to take additional drugs to manage their symptoms. One class of drugs, called catechol-O-methyltransferase inhibitors […]
Long-term opioid prescribing has fallen in the United States over the last decade, but millions of patients still received opioids for 90 days or longer in 2023, according to a new research letter in JAMA […]
23andMe Research Institute, a nonprofit medical research organization, announced the publication of a study that identifies genetic predictors for GLP-1 weight loss efficacy and side effects. GLP-1 receptor agonists, including semaglutide and tirzepatide, have transformed […]
© 2025 SimplyWell.ca